Senior insider sale
Chief Development Officer at ALDEYRA THERAPEUTICS, INC. — senior position signals high conviction
$116.1K
22.07K shares
What this filing means
MACHATHA STEPHEN plans to sell 22.07K shares of ALDEYRA THERAPEUTICS, INC. valued at approximately $116.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2025ACC: 0001836354-25-000003
Officer· Chief Development Officer
Since Dec 2020
22.07K
Shares to sell
$116.1K
Approx. market value
46.40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Services rendered
7/15/2022
46.40KTotal acquired46.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/15/2022 | Restricted Stock Unit Grant Services rendered | 46.40K | — |
| Total | 46.40K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
22.07K
Market value
$116.1K
8/12/2025
Total
Units
22.07K
Value
$116.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2025 | 22.07K | $116.1K | Nasdaq | Planned |
| Total | 22.07K | $116.1K | ||